Omnicell
SEPTEMBER 5, 2022
Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. Injectable medications cause 1.2
Omnicell
JANUARY 10, 2023
Many often rely on 503B outsourcing pharmacies for their pre-mixed compounded sterile products. At the University of Maryland Medical Center, we reduced our need for 503B vendors by implementing an IV robotics insourcing program for compounded sterile products (CSPs).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 24, 2023
MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting , a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.
pharmaphorum
DECEMBER 5, 2022
A vast majority of patients diagnosed with CRPC already present with metastases at the time of diagnosis. The findings will be presented at an upcoming medical meeting and submitted to the FDA for regulatory approval in 2023. Prostate cancer is the most frequently diagnosed cancer in men in 112 countries.
The FDA Law Blog
AUGUST 14, 2023
Farquhar — At the GMP by the Sea Conference ongoing in Cambridge, Maryland, a presentation was made by a representative of FDA’s Center for Drug Evaluation and Research that shows some interesting trends in enforcement. By Douglas B. OAI is FDA’s classification for facilities it deems to be in an unacceptable state of compliance.
Pharmaceutical Technology
FEBRUARY 24, 2023
The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, otherwise known as net present value (NPV). It uses state-of-the-art technology platforms to discover new disease targets, compounds, delivery mechanisms, and treatment modalities. million in FY2021.
Omnicell
JANUARY 10, 2023
See how Omnicell is transforming pharmacy care at Booth #1213 in the Exhibit Hall, where you can explore our full portfolio of services for central pharmacy and IV compounding robotics, point-of-care dispensing, inventory optimization, specialty pharmacy, and retail pharmacy. ASHP Midyear is more than a meeting.
Expert insights. Personalized for you.
52 
Let's personalize your content